nodes	percent_of_prediction	percent_of_DWPC	metapath
Rivaroxaban—CYP3A5—Beclomethasone—asthma	0.0523	0.0764	CbGbCtD
Rivaroxaban—CYP3A5—Salmeterol—asthma	0.0523	0.0764	CbGbCtD
Rivaroxaban—ABCB1—Fluticasone furoate—asthma	0.0449	0.0656	CbGbCtD
Rivaroxaban—CYP3A5—Fluticasone Propionate—asthma	0.0444	0.065	CbGbCtD
Rivaroxaban—ABCB1—Indacaterol—asthma	0.0366	0.0535	CbGbCtD
Rivaroxaban—CYP3A4—Fluticasone furoate—asthma	0.0269	0.0393	CbGbCtD
Rivaroxaban—CYP3A4—Budesonide—asthma	0.024	0.035	CbGbCtD
Rivaroxaban—CYP3A4—Ciclesonide—asthma	0.0219	0.032	CbGbCtD
Rivaroxaban—CYP3A4—Indacaterol—asthma	0.0219	0.032	CbGbCtD
Rivaroxaban—CYP3A4—Salmeterol—asthma	0.0204	0.0298	CbGbCtD
Rivaroxaban—CYP3A4—Salbutamol—asthma	0.0204	0.0298	CbGbCtD
Rivaroxaban—CYP3A4—Flunisolide—asthma	0.0204	0.0298	CbGbCtD
Rivaroxaban—ABCB1—Loratadine—asthma	0.0195	0.0286	CbGbCtD
Rivaroxaban—CYP3A4—Zileuton—asthma	0.0182	0.0266	CbGbCtD
Rivaroxaban—CYP3A4—Ipratropium bromide—asthma	0.0182	0.0266	CbGbCtD
Rivaroxaban—ABCB1—Methylprednisolone—asthma	0.0179	0.0261	CbGbCtD
Rivaroxaban—CYP3A4—Fluticasone Propionate—asthma	0.0173	0.0253	CbGbCtD
Rivaroxaban—CYP3A5—Hydrocortisone—asthma	0.0167	0.0244	CbGbCtD
Rivaroxaban—CYP3A4—Zafirlukast—asthma	0.016	0.0234	CbGbCtD
Rivaroxaban—CYP3A4—Tiotropium—asthma	0.0138	0.0201	CbGbCtD
Rivaroxaban—CYP3A4—Aminophylline—asthma	0.0131	0.0192	CbGbCtD
Rivaroxaban—CYP3A4—Theophylline—asthma	0.0123	0.018	CbGbCtD
Rivaroxaban—CYP3A4—Montelukast—asthma	0.0117	0.0171	CbGbCtD
Rivaroxaban—CYP3A4—Loratadine—asthma	0.0117	0.0171	CbGbCtD
Rivaroxaban—ABCB1—Betamethasone—asthma	0.0116	0.017	CbGbCtD
Rivaroxaban—ABCB1—Prednisolone—asthma	0.0115	0.0168	CbGbCtD
Rivaroxaban—ABCB1—Hydrocortisone—asthma	0.0109	0.0159	CbGbCtD
Rivaroxaban—ABCB1—Prednisone—asthma	0.0108	0.0158	CbGbCtD
Rivaroxaban—CYP3A4—Methylprednisolone—asthma	0.0107	0.0156	CbGbCtD
Rivaroxaban—CYP3A5—Dexamethasone—asthma	0.0104	0.0152	CbGbCtD
Rivaroxaban—CYP3A4—Triamcinolone—asthma	0.00811	0.0119	CbGbCtD
Rivaroxaban—CYP3A4—Betamethasone—asthma	0.00696	0.0102	CbGbCtD
Rivaroxaban—CYP3A4—Prednisolone—asthma	0.00687	0.01	CbGbCtD
Rivaroxaban—ABCB1—Dexamethasone—asthma	0.00676	0.00988	CbGbCtD
Rivaroxaban—CYP3A4—Hydrocortisone—asthma	0.00651	0.00952	CbGbCtD
Rivaroxaban—CYP3A4—Prednisone—asthma	0.00649	0.00948	CbGbCtD
Rivaroxaban—CYP3A4—Dexamethasone—asthma	0.00405	0.00592	CbGbCtD
Rivaroxaban—F10—cardiovascular system—asthma	0.000938	0.139	CbGeAlD
Rivaroxaban—CYP2J2—bronchus—asthma	0.000826	0.123	CbGeAlD
Rivaroxaban—CYP2J2—cardiovascular system—asthma	0.000769	0.114	CbGeAlD
Rivaroxaban—F10—adrenal gland—asthma	0.000742	0.11	CbGeAlD
Rivaroxaban—CYP2J2—trachea—asthma	0.000742	0.11	CbGeAlD
Rivaroxaban—F10—lung—asthma	0.00065	0.0965	CbGeAlD
Rivaroxaban—CYP2J2—lung—asthma	0.000533	0.0791	CbGeAlD
Rivaroxaban—CYP3A5—respiratory system—asthma	0.000353	0.0524	CbGeAlD
Rivaroxaban—CYP2J2—Metabolism of lipids and lipoproteins—LTC4S—asthma	0.000326	0.00607	CbGpPWpGaD
Rivaroxaban—CYP3A4—Fatty Acid Omega Oxidation—ALDH2—asthma	0.000322	0.00599	CbGpPWpGaD
Rivaroxaban—ABCB1—Drug Induction of Bile Acid Pathway—VDR—asthma	0.00031	0.00577	CbGpPWpGaD
Rivaroxaban—CYP2J2—Phase 1 - Functionalization of compounds—POMC—asthma	0.00029	0.00539	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism of lipids and lipoproteins—LTA4H—asthma	0.000283	0.00526	CbGpPWpGaD
Rivaroxaban—F10—Metabolism of proteins—MUC5AC—asthma	0.000248	0.00462	CbGpPWpGaD
Rivaroxaban—F10—Hemostasis—CSF2RB—asthma	0.000244	0.00454	CbGpPWpGaD
Rivaroxaban—CYP2J2—Biological oxidations—GSTP1—asthma	0.000237	0.00441	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metapathway biotransformation—GSTP1—asthma	0.000234	0.00435	CbGpPWpGaD
Rivaroxaban—CYP3A4—Estrogen metabolism—NQO1—asthma	0.000232	0.00431	CbGpPWpGaD
Rivaroxaban—CYP2J2—Biological oxidations—GSTM1—asthma	0.000218	0.00405	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metapathway biotransformation—GSTM1—asthma	0.000215	0.004	CbGpPWpGaD
Rivaroxaban—F10—Hemostasis—KIF3A—asthma	0.000209	0.00389	CbGpPWpGaD
Rivaroxaban—CYP3A5—Phase 1 - Functionalization of compounds—ALDH2—asthma	0.000195	0.00363	CbGpPWpGaD
Rivaroxaban—CYP3A4—Drug Induction of Bile Acid Pathway—VDR—asthma	0.000191	0.00356	CbGpPWpGaD
Rivaroxaban—F10—Metabolism of proteins—SLC30A8—asthma	0.000188	0.0035	CbGpPWpGaD
Rivaroxaban—ABCB1—respiratory system—asthma	0.000188	0.0279	CbGeAlD
Rivaroxaban—CYP3A5—lung—asthma	0.000188	0.0278	CbGeAlD
Rivaroxaban—ABCB1—Allograft Rejection—PRF1—asthma	0.000187	0.00349	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metapathway biotransformation—HNMT—asthma	0.000185	0.00345	CbGpPWpGaD
Rivaroxaban—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—asthma	0.000178	0.00332	CbGpPWpGaD
Rivaroxaban—CYP3A4—Estrogen metabolism—GSTM1—asthma	0.000178	0.00331	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism of lipids and lipoproteins—ALOX15—asthma	0.000177	0.0033	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism of lipids and lipoproteins—ALOX5AP—asthma	0.000177	0.0033	CbGpPWpGaD
Rivaroxaban—F10—Hemostasis—MYB—asthma	0.000174	0.00325	CbGpPWpGaD
Rivaroxaban—F10—Hemostasis—IL2RB—asthma	0.000174	0.00325	CbGpPWpGaD
Rivaroxaban—F10—Metabolism of proteins—PLA2G7—asthma	0.000172	0.0032	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism of lipids and lipoproteins—CHAT—asthma	0.000169	0.00315	CbGpPWpGaD
Rivaroxaban—ABCB1—Allograft Rejection—FOXP3—asthma	0.000165	0.00307	CbGpPWpGaD
Rivaroxaban—ABCB1—Allograft Rejection—C5—asthma	0.000159	0.00297	CbGpPWpGaD
Rivaroxaban—F10—Hemostasis—SERPINA1—asthma	0.000158	0.00295	CbGpPWpGaD
Rivaroxaban—ABCB1—adrenal cortex—asthma	0.000158	0.0234	CbGeAlD
Rivaroxaban—ABCB1—epithelium—asthma	0.000157	0.0233	CbGeAlD
Rivaroxaban—CYP2J2—Biological oxidations—POMC—asthma	0.000154	0.00287	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism of lipids and lipoproteins—ALOX5—asthma	0.000151	0.00281	CbGpPWpGaD
Rivaroxaban—ABCB1—Allograft Rejection—HLA-G—asthma	0.00015	0.00279	CbGpPWpGaD
Rivaroxaban—F10—Metabolism of proteins—CMA1—asthma	0.000149	0.00277	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism—LTC4S—asthma	0.000145	0.0027	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism of lipids and lipoproteins—CARM1—asthma	0.000144	0.00268	CbGpPWpGaD
Rivaroxaban—ABCB1—cardiovascular system—asthma	0.000144	0.0213	CbGeAlD
Rivaroxaban—ABCB1—Allograft Rejection—IL13—asthma	0.000141	0.00263	CbGpPWpGaD
Rivaroxaban—ABCB1—trachea—asthma	0.000139	0.0206	CbGeAlD
Rivaroxaban—CYP3A4—Tryptophan metabolism—ALDH2—asthma	0.000138	0.00258	CbGpPWpGaD
Rivaroxaban—F10—Hemostasis—GATA3—asthma	0.000135	0.00251	CbGpPWpGaD
Rivaroxaban—ABCB1—Allograft Rejection—IL17A—asthma	0.00013	0.00242	CbGpPWpGaD
Rivaroxaban—F10—Hemostasis—IL5—asthma	0.000128	0.00238	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism—LTA4H—asthma	0.000126	0.00234	CbGpPWpGaD
Rivaroxaban—ABCB1—Allograft Rejection—IL12B—asthma	0.000121	0.00225	CbGpPWpGaD
Rivaroxaban—ABCB1—Allograft Rejection—IL5—asthma	0.000121	0.00225	CbGpPWpGaD
Rivaroxaban—F10—Hemostasis—NOS1—asthma	0.00012	0.00223	CbGpPWpGaD
Rivaroxaban—ABCB1—Allograft Rejection—HLA-DPB1—asthma	0.00012	0.00223	CbGpPWpGaD
Rivaroxaban—F10—Hemostasis—IL3—asthma	0.000119	0.00221	CbGpPWpGaD
Rivaroxaban—ABCB1—Allograft Rejection—CD40—asthma	0.000115	0.00214	CbGpPWpGaD
Rivaroxaban—ABCB1—adrenal gland—asthma	0.000114	0.0169	CbGeAlD
Rivaroxaban—ABCB1—Allograft Rejection—CTLA4—asthma	0.000113	0.00211	CbGpPWpGaD
Rivaroxaban—F10—Hemostasis—KNG1—asthma	0.000112	0.00209	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism—ARG1—asthma	0.00011	0.00205	CbGpPWpGaD
Rivaroxaban—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—asthma	0.00011	0.00204	CbGpPWpGaD
Rivaroxaban—ABCB1—HIF-1-alpha transcription factor network—HMOX1—asthma	0.000109	0.00204	CbGpPWpGaD
Rivaroxaban—ABCB1—Allograft Rejection—AGTR1—asthma	0.000105	0.00196	CbGpPWpGaD
Rivaroxaban—ABCB1—Integrated Pancreatic Cancer Pathway—RAD50—asthma	0.000104	0.00193	CbGpPWpGaD
Rivaroxaban—CYP3A5—Biological oxidations—ALDH2—asthma	0.000104	0.00193	CbGpPWpGaD
Rivaroxaban—ABCB1—HIF-1-alpha transcription factor network—EDN1—asthma	0.000103	0.00192	CbGpPWpGaD
Rivaroxaban—CYP3A5—Cytochrome P450 - arranged by substrate type—POMC—asthma	0.000103	0.00192	CbGpPWpGaD
Rivaroxaban—Pruritus—Budesonide—asthma	0.000102	0.000399	CcSEcCtD
Rivaroxaban—Diarrhoea—Salbutamol—asthma	0.000102	0.000398	CcSEcCtD
Rivaroxaban—Haemoglobin—Betamethasone—asthma	0.000101	0.000394	CcSEcCtD
Rivaroxaban—Haemoglobin—Dexamethasone—asthma	0.000101	0.000394	CcSEcCtD
Rivaroxaban—Haemorrhage—Dexamethasone—asthma	0.0001	0.000392	CcSEcCtD
Rivaroxaban—Haemorrhage—Betamethasone—asthma	0.0001	0.000392	CcSEcCtD
Rivaroxaban—Vomiting—Formoterol—asthma	0.0001	0.000392	CcSEcCtD
Rivaroxaban—Vomiting—Arformoterol—asthma	0.0001	0.000392	CcSEcCtD
Rivaroxaban—ABCB1—Allograft Rejection—HLA-DQA1—asthma	9.99e-05	0.00186	CbGpPWpGaD
Rivaroxaban—F10—Hemostasis—ITPR1—asthma	9.99e-05	0.00186	CbGpPWpGaD
Rivaroxaban—Angiopathy—Methylprednisolone—asthma	9.99e-05	0.000391	CcSEcCtD
Rivaroxaban—ABCB1—lung—asthma	9.96e-05	0.0148	CbGeAlD
Rivaroxaban—Nausea—Mometasone—asthma	9.96e-05	0.00039	CcSEcCtD
Rivaroxaban—CYP2J2—Metabolism—ALDH7A1—asthma	9.95e-05	0.00185	CbGpPWpGaD
Rivaroxaban—Immune system disorder—Methylprednisolone—asthma	9.94e-05	0.000389	CcSEcCtD
Rivaroxaban—Rash—Formoterol—asthma	9.92e-05	0.000389	CcSEcCtD
Rivaroxaban—Rash—Arformoterol—asthma	9.92e-05	0.000389	CcSEcCtD
Rivaroxaban—Mediastinal disorder—Methylprednisolone—asthma	9.92e-05	0.000388	CcSEcCtD
Rivaroxaban—Dermatitis—Arformoterol—asthma	9.91e-05	0.000388	CcSEcCtD
Rivaroxaban—Dermatitis—Formoterol—asthma	9.91e-05	0.000388	CcSEcCtD
Rivaroxaban—Headache—Formoterol—asthma	9.86e-05	0.000386	CcSEcCtD
Rivaroxaban—Headache—Arformoterol—asthma	9.86e-05	0.000386	CcSEcCtD
Rivaroxaban—CYP3A5—Biological oxidations—GSTT1—asthma	9.85e-05	0.00183	CbGpPWpGaD
Rivaroxaban—Diarrhoea—Budesonide—asthma	9.85e-05	0.000386	CcSEcCtD
Rivaroxaban—Dizziness—Salbutamol—asthma	9.83e-05	0.000385	CcSEcCtD
Rivaroxaban—ABCB1—HIF-1-alpha transcription factor network—SMAD3—asthma	9.81e-05	0.00183	CbGpPWpGaD
Rivaroxaban—Vomiting—Montelukast—asthma	9.8e-05	0.000384	CcSEcCtD
Rivaroxaban—F10—Metabolism of proteins—ACE—asthma	9.72e-05	0.00181	CbGpPWpGaD
Rivaroxaban—Rash—Montelukast—asthma	9.72e-05	0.000381	CcSEcCtD
Rivaroxaban—Dermatitis—Montelukast—asthma	9.71e-05	0.00038	CcSEcCtD
Rivaroxaban—Ill-defined disorder—Prednisolone—asthma	9.69e-05	0.000379	CcSEcCtD
Rivaroxaban—Headache—Montelukast—asthma	9.66e-05	0.000378	CcSEcCtD
Rivaroxaban—Angioedema—Prednisolone—asthma	9.54e-05	0.000374	CcSEcCtD
Rivaroxaban—CYP2J2—Metabolism—ARG2—asthma	9.54e-05	0.00178	CbGpPWpGaD
Rivaroxaban—Dizziness—Budesonide—asthma	9.52e-05	0.000373	CcSEcCtD
Rivaroxaban—Ill-defined disorder—Hydrocortisone—asthma	9.46e-05	0.000371	CcSEcCtD
Rivaroxaban—Vomiting—Salbutamol—asthma	9.45e-05	0.00037	CcSEcCtD
Rivaroxaban—Malaise—Prednisolone—asthma	9.42e-05	0.000369	CcSEcCtD
Rivaroxaban—Rash—Salbutamol—asthma	9.37e-05	0.000367	CcSEcCtD
Rivaroxaban—Syncope—Prednisolone—asthma	9.36e-05	0.000367	CcSEcCtD
Rivaroxaban—Dermatitis—Salbutamol—asthma	9.36e-05	0.000367	CcSEcCtD
Rivaroxaban—Eye disorder—Betamethasone—asthma	9.35e-05	0.000366	CcSEcCtD
Rivaroxaban—Eye disorder—Dexamethasone—asthma	9.35e-05	0.000366	CcSEcCtD
Rivaroxaban—Nausea—Arformoterol—asthma	9.35e-05	0.000366	CcSEcCtD
Rivaroxaban—Nausea—Formoterol—asthma	9.35e-05	0.000366	CcSEcCtD
Rivaroxaban—ABCB1—Allograft Rejection—HLA-DQB1—asthma	9.34e-05	0.00174	CbGpPWpGaD
Rivaroxaban—F10—Hemostasis—PLA2G4A—asthma	9.33e-05	0.00174	CbGpPWpGaD
Rivaroxaban—Angioedema—Hydrocortisone—asthma	9.32e-05	0.000365	CcSEcCtD
Rivaroxaban—Headache—Salbutamol—asthma	9.31e-05	0.000365	CcSEcCtD
Rivaroxaban—Back pain—Triamcinolone—asthma	9.29e-05	0.000364	CcSEcCtD
Rivaroxaban—ABCB1—Integrated Pancreatic Cancer Pathway—IL1R1—asthma	9.24e-05	0.00172	CbGpPWpGaD
Rivaroxaban—F10—Hemostasis—CSF2—asthma	9.23e-05	0.00172	CbGpPWpGaD
Rivaroxaban—Malaise—Hydrocortisone—asthma	9.2e-05	0.00036	CcSEcCtD
Rivaroxaban—Loss of consciousness—Prednisolone—asthma	9.18e-05	0.000359	CcSEcCtD
Rivaroxaban—Nausea—Montelukast—asthma	9.16e-05	0.000359	CcSEcCtD
Rivaroxaban—Vomiting—Budesonide—asthma	9.15e-05	0.000358	CcSEcCtD
Rivaroxaban—Syncope—Hydrocortisone—asthma	9.15e-05	0.000358	CcSEcCtD
Rivaroxaban—Angiopathy—Dexamethasone—asthma	9.08e-05	0.000356	CcSEcCtD
Rivaroxaban—Angiopathy—Betamethasone—asthma	9.08e-05	0.000356	CcSEcCtD
Rivaroxaban—Rash—Budesonide—asthma	9.07e-05	0.000355	CcSEcCtD
Rivaroxaban—Dermatitis—Budesonide—asthma	9.07e-05	0.000355	CcSEcCtD
Rivaroxaban—CYP3A4—Phase 1 - Functionalization of compounds—ALDH2—asthma	9.07e-05	0.00169	CbGpPWpGaD
Rivaroxaban—Headache—Budesonide—asthma	9.02e-05	0.000353	CcSEcCtD
Rivaroxaban—ABCB1—Allograft Rejection—CD86—asthma	9e-05	0.00168	CbGpPWpGaD
Rivaroxaban—Loss of consciousness—Hydrocortisone—asthma	8.96e-05	0.000351	CcSEcCtD
Rivaroxaban—Ill-defined disorder—Triamcinolone—asthma	8.91e-05	0.000349	CcSEcCtD
Rivaroxaban—Ill-defined disorder—Methylprednisolone—asthma	8.89e-05	0.000348	CcSEcCtD
Rivaroxaban—CYP3A4—Tryptophan metabolism—CAT—asthma	8.87e-05	0.00165	CbGpPWpGaD
Rivaroxaban—Nausea—Salbutamol—asthma	8.83e-05	0.000346	CcSEcCtD
Rivaroxaban—ABCB1—Allograft Rejection—IL10—asthma	8.82e-05	0.00164	CbGpPWpGaD
Rivaroxaban—ABCB1—Allograft Rejection—CD40LG—asthma	8.82e-05	0.00164	CbGpPWpGaD
Rivaroxaban—Discomfort—Prednisolone—asthma	8.78e-05	0.000344	CcSEcCtD
Rivaroxaban—Angioedema—Triamcinolone—asthma	8.77e-05	0.000344	CcSEcCtD
Rivaroxaban—Haemoglobin—Prednisone—asthma	8.76e-05	0.000343	CcSEcCtD
Rivaroxaban—Angioedema—Methylprednisolone—asthma	8.76e-05	0.000343	CcSEcCtD
Rivaroxaban—Haemorrhage—Prednisone—asthma	8.72e-05	0.000341	CcSEcCtD
Rivaroxaban—Malaise—Triamcinolone—asthma	8.66e-05	0.000339	CcSEcCtD
Rivaroxaban—Malaise—Methylprednisolone—asthma	8.64e-05	0.000338	CcSEcCtD
Rivaroxaban—Unspecified disorder of skin and subcutaneous tissue—Hydrocortisone—asthma	8.62e-05	0.000338	CcSEcCtD
Rivaroxaban—Syncope—Triamcinolone—asthma	8.61e-05	0.000337	CcSEcCtD
Rivaroxaban—Syncope—Methylprednisolone—asthma	8.59e-05	0.000336	CcSEcCtD
Rivaroxaban—F10—Hemostasis—PPP2CA—asthma	8.59e-05	0.0016	CbGpPWpGaD
Rivaroxaban—ABCB1—Allograft Rejection—IL4—asthma	8.58e-05	0.0016	CbGpPWpGaD
Rivaroxaban—Discomfort—Hydrocortisone—asthma	8.58e-05	0.000336	CcSEcCtD
Rivaroxaban—Connective tissue disorder—Prednisone—asthma	8.57e-05	0.000335	CcSEcCtD
Rivaroxaban—Nausea—Budesonide—asthma	8.55e-05	0.000335	CcSEcCtD
Rivaroxaban—Oedema—Prednisolone—asthma	8.52e-05	0.000334	CcSEcCtD
Rivaroxaban—Anaphylactic shock—Prednisolone—asthma	8.52e-05	0.000334	CcSEcCtD
Rivaroxaban—Loss of consciousness—Triamcinolone—asthma	8.44e-05	0.000331	CcSEcCtD
Rivaroxaban—ABCB1—Transmembrane transport of small molecules—TRPA1—asthma	8.43e-05	0.00157	CbGpPWpGaD
Rivaroxaban—Loss of consciousness—Methylprednisolone—asthma	8.42e-05	0.00033	CcSEcCtD
Rivaroxaban—Shock—Prednisolone—asthma	8.38e-05	0.000328	CcSEcCtD
Rivaroxaban—ABCB1—HIF-1-alpha transcription factor network—LEP—asthma	8.38e-05	0.00156	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism of lipids and lipoproteins—PLA2G4A—asthma	8.36e-05	0.00156	CbGpPWpGaD
Rivaroxaban—CYP3A5—Phase 1 - Functionalization of compounds—POMC—asthma	8.35e-05	0.00155	CbGpPWpGaD
Rivaroxaban—Oedema—Hydrocortisone—asthma	8.32e-05	0.000326	CcSEcCtD
Rivaroxaban—Anaphylactic shock—Hydrocortisone—asthma	8.32e-05	0.000326	CcSEcCtD
Rivaroxaban—Tachycardia—Prednisolone—asthma	8.32e-05	0.000326	CcSEcCtD
Rivaroxaban—F10—Hemostasis—IL2RA—asthma	8.32e-05	0.00155	CbGpPWpGaD
Rivaroxaban—Infection—Hydrocortisone—asthma	8.27e-05	0.000324	CcSEcCtD
Rivaroxaban—Shock—Hydrocortisone—asthma	8.19e-05	0.000321	CcSEcCtD
Rivaroxaban—Nervous system disorder—Hydrocortisone—asthma	8.16e-05	0.00032	CcSEcCtD
Rivaroxaban—Eye disorder—Prednisone—asthma	8.15e-05	0.000319	CcSEcCtD
Rivaroxaban—Tachycardia—Hydrocortisone—asthma	8.12e-05	0.000318	CcSEcCtD
Rivaroxaban—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—asthma	8.1e-05	0.000317	CcSEcCtD
Rivaroxaban—Skin disorder—Hydrocortisone—asthma	8.08e-05	0.000317	CcSEcCtD
Rivaroxaban—Ill-defined disorder—Betamethasone—asthma	8.08e-05	0.000317	CcSEcCtD
Rivaroxaban—Ill-defined disorder—Dexamethasone—asthma	8.08e-05	0.000317	CcSEcCtD
Rivaroxaban—Discomfort—Triamcinolone—asthma	8.08e-05	0.000316	CcSEcCtD
Rivaroxaban—Discomfort—Methylprednisolone—asthma	8.06e-05	0.000316	CcSEcCtD
Rivaroxaban—F10—Hemostasis—PDGFB—asthma	8.03e-05	0.00149	CbGpPWpGaD
Rivaroxaban—Dry mouth—Triamcinolone—asthma	8e-05	0.000313	CcSEcCtD
Rivaroxaban—Angioedema—Dexamethasone—asthma	7.96e-05	0.000312	CcSEcCtD
Rivaroxaban—Angioedema—Betamethasone—asthma	7.96e-05	0.000312	CcSEcCtD
Rivaroxaban—Angiopathy—Prednisone—asthma	7.91e-05	0.00031	CcSEcCtD
Rivaroxaban—CYP2J2—Metabolism—ALOX15—asthma	7.9e-05	0.00147	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism—ALOX5AP—asthma	7.9e-05	0.00147	CbGpPWpGaD
Rivaroxaban—Immune system disorder—Prednisone—asthma	7.87e-05	0.000308	CcSEcCtD
Rivaroxaban—ABCB1—Allograft Rejection—IL2RA—asthma	7.87e-05	0.00146	CbGpPWpGaD
Rivaroxaban—Malaise—Betamethasone—asthma	7.86e-05	0.000308	CcSEcCtD
Rivaroxaban—Malaise—Dexamethasone—asthma	7.86e-05	0.000308	CcSEcCtD
Rivaroxaban—Oedema—Triamcinolone—asthma	7.84e-05	0.000307	CcSEcCtD
Rivaroxaban—Anaphylactic shock—Triamcinolone—asthma	7.84e-05	0.000307	CcSEcCtD
Rivaroxaban—Anaphylactic shock—Methylprednisolone—asthma	7.82e-05	0.000306	CcSEcCtD
Rivaroxaban—Syncope—Dexamethasone—asthma	7.81e-05	0.000306	CcSEcCtD
Rivaroxaban—Syncope—Betamethasone—asthma	7.81e-05	0.000306	CcSEcCtD
Rivaroxaban—ABCB1—HIF-1-alpha transcription factor network—NOS2—asthma	7.81e-05	0.00145	CbGpPWpGaD
Rivaroxaban—ABCB1—Allograft Rejection—C3—asthma	7.8e-05	0.00145	CbGpPWpGaD
Rivaroxaban—F10—Hemostasis—CDK2—asthma	7.79e-05	0.00145	CbGpPWpGaD
Rivaroxaban—F10—Hemostasis—PLAU—asthma	7.79e-05	0.00145	CbGpPWpGaD
Rivaroxaban—Infection—Triamcinolone—asthma	7.79e-05	0.000305	CcSEcCtD
Rivaroxaban—Hypotension—Hydrocortisone—asthma	7.78e-05	0.000305	CcSEcCtD
Rivaroxaban—Infection—Methylprednisolone—asthma	7.77e-05	0.000304	CcSEcCtD
Rivaroxaban—Shock—Triamcinolone—asthma	7.71e-05	0.000302	CcSEcCtD
Rivaroxaban—Shock—Methylprednisolone—asthma	7.69e-05	0.000301	CcSEcCtD
Rivaroxaban—Nervous system disorder—Methylprednisolone—asthma	7.67e-05	0.0003	CcSEcCtD
Rivaroxaban—Loss of consciousness—Dexamethasone—asthma	7.66e-05	0.0003	CcSEcCtD
Rivaroxaban—Loss of consciousness—Betamethasone—asthma	7.66e-05	0.0003	CcSEcCtD
Rivaroxaban—Tachycardia—Triamcinolone—asthma	7.65e-05	0.0003	CcSEcCtD
Rivaroxaban—Tachycardia—Methylprednisolone—asthma	7.63e-05	0.000299	CcSEcCtD
Rivaroxaban—Skin disorder—Methylprednisolone—asthma	7.6e-05	0.000297	CcSEcCtD
Rivaroxaban—CYP2J2—Metabolism—CHAT—asthma	7.54e-05	0.0014	CbGpPWpGaD
Rivaroxaban—Discomfort—Betamethasone—asthma	7.33e-05	0.000287	CcSEcCtD
Rivaroxaban—Discomfort—Dexamethasone—asthma	7.33e-05	0.000287	CcSEcCtD
Rivaroxaban—Dyspepsia—Hydrocortisone—asthma	7.33e-05	0.000287	CcSEcCtD
Rivaroxaban—Hypotension—Methylprednisolone—asthma	7.31e-05	0.000286	CcSEcCtD
Rivaroxaban—Pain—Prednisolone—asthma	7.29e-05	0.000285	CcSEcCtD
Rivaroxaban—F10—Hemostasis—FN1—asthma	7.24e-05	0.00135	CbGpPWpGaD
Rivaroxaban—Gastrointestinal disorder—Hydrocortisone—asthma	7.19e-05	0.000281	CcSEcCtD
Rivaroxaban—Fatigue—Hydrocortisone—asthma	7.18e-05	0.000281	CcSEcCtD
Rivaroxaban—F10—Hemostasis—NOS2—asthma	7.15e-05	0.00133	CbGpPWpGaD
Rivaroxaban—Pain—Hydrocortisone—asthma	7.12e-05	0.000279	CcSEcCtD
Rivaroxaban—Anaphylactic shock—Dexamethasone—asthma	7.11e-05	0.000278	CcSEcCtD
Rivaroxaban—Oedema—Betamethasone—asthma	7.11e-05	0.000278	CcSEcCtD
Rivaroxaban—Anaphylactic shock—Betamethasone—asthma	7.11e-05	0.000278	CcSEcCtD
Rivaroxaban—Oedema—Dexamethasone—asthma	7.11e-05	0.000278	CcSEcCtD
Rivaroxaban—ABCB1—Allograft Rejection—HLA-DRB1—asthma	7.11e-05	0.00132	CbGpPWpGaD
Rivaroxaban—Infection—Betamethasone—asthma	7.06e-05	0.000277	CcSEcCtD
Rivaroxaban—Infection—Dexamethasone—asthma	7.06e-05	0.000277	CcSEcCtD
Rivaroxaban—Ill-defined disorder—Prednisone—asthma	7.04e-05	0.000276	CcSEcCtD
Rivaroxaban—Feeling abnormal—Prednisolone—asthma	7.02e-05	0.000275	CcSEcCtD
Rivaroxaban—Anaemia—Prednisone—asthma	7.01e-05	0.000275	CcSEcCtD
Rivaroxaban—Shock—Dexamethasone—asthma	7e-05	0.000274	CcSEcCtD
Rivaroxaban—Shock—Betamethasone—asthma	7e-05	0.000274	CcSEcCtD
Rivaroxaban—Dyspnoea—Triamcinolone—asthma	6.99e-05	0.000274	CcSEcCtD
Rivaroxaban—Nervous system disorder—Dexamethasone—asthma	6.97e-05	0.000273	CcSEcCtD
Rivaroxaban—Nervous system disorder—Betamethasone—asthma	6.97e-05	0.000273	CcSEcCtD
Rivaroxaban—Tachycardia—Dexamethasone—asthma	6.94e-05	0.000272	CcSEcCtD
Rivaroxaban—Tachycardia—Betamethasone—asthma	6.94e-05	0.000272	CcSEcCtD
Rivaroxaban—Angioedema—Prednisone—asthma	6.93e-05	0.000272	CcSEcCtD
Rivaroxaban—Dyspepsia—Triamcinolone—asthma	6.9e-05	0.00027	CcSEcCtD
Rivaroxaban—Dyspepsia—Methylprednisolone—asthma	6.88e-05	0.00027	CcSEcCtD
Rivaroxaban—Feeling abnormal—Hydrocortisone—asthma	6.86e-05	0.000269	CcSEcCtD
Rivaroxaban—Malaise—Prednisone—asthma	6.84e-05	0.000268	CcSEcCtD
Rivaroxaban—CYP3A5—Biological oxidations—GSTP1—asthma	6.83e-05	0.00127	CbGpPWpGaD
Rivaroxaban—Gastrointestinal pain—Hydrocortisone—asthma	6.81e-05	0.000267	CcSEcCtD
Rivaroxaban—Syncope—Prednisone—asthma	6.8e-05	0.000266	CcSEcCtD
Rivaroxaban—Urticaria—Prednisolone—asthma	6.77e-05	0.000265	CcSEcCtD
Rivaroxaban—Fatigue—Triamcinolone—asthma	6.76e-05	0.000265	CcSEcCtD
Rivaroxaban—Fatigue—Methylprednisolone—asthma	6.74e-05	0.000264	CcSEcCtD
Rivaroxaban—CYP3A5—Metapathway biotransformation—GSTP1—asthma	6.74e-05	0.00125	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism—ALOX5—asthma	6.72e-05	0.00125	CbGpPWpGaD
Rivaroxaban—Pain—Triamcinolone—asthma	6.7e-05	0.000262	CcSEcCtD
Rivaroxaban—Loss of consciousness—Prednisone—asthma	6.67e-05	0.000261	CcSEcCtD
Rivaroxaban—Hypotension—Dexamethasone—asthma	6.64e-05	0.00026	CcSEcCtD
Rivaroxaban—Hypotension—Betamethasone—asthma	6.64e-05	0.00026	CcSEcCtD
Rivaroxaban—Urticaria—Hydrocortisone—asthma	6.61e-05	0.000259	CcSEcCtD
Rivaroxaban—Abdominal pain—Hydrocortisone—asthma	6.58e-05	0.000258	CcSEcCtD
Rivaroxaban—ABCB1—HIF-1-alpha transcription factor network—SERPINE1—asthma	6.58e-05	0.00122	CbGpPWpGaD
Rivaroxaban—Feeling abnormal—Triamcinolone—asthma	6.46e-05	0.000253	CcSEcCtD
Rivaroxaban—Feeling abnormal—Methylprednisolone—asthma	6.44e-05	0.000252	CcSEcCtD
Rivaroxaban—Unspecified disorder of skin and subcutaneous tissue—Prednisone—asthma	6.42e-05	0.000251	CcSEcCtD
Rivaroxaban—CYP2J2—Metabolism—CARM1—asthma	6.41e-05	0.00119	CbGpPWpGaD
Rivaroxaban—Gastrointestinal pain—Methylprednisolone—asthma	6.39e-05	0.00025	CcSEcCtD
Rivaroxaban—Discomfort—Prednisone—asthma	6.38e-05	0.00025	CcSEcCtD
Rivaroxaban—CYP2J2—Metabolism—DCN—asthma	6.32e-05	0.00118	CbGpPWpGaD
Rivaroxaban—Hypersensitivity—Prednisolone—asthma	6.28e-05	0.000246	CcSEcCtD
Rivaroxaban—CYP3A5—Biological oxidations—GSTM1—asthma	6.28e-05	0.00117	CbGpPWpGaD
Rivaroxaban—Dyspepsia—Betamethasone—asthma	6.26e-05	0.000245	CcSEcCtD
Rivaroxaban—Dyspepsia—Dexamethasone—asthma	6.26e-05	0.000245	CcSEcCtD
Rivaroxaban—Urticaria—Triamcinolone—asthma	6.23e-05	0.000244	CcSEcCtD
Rivaroxaban—Urticaria—Methylprednisolone—asthma	6.21e-05	0.000243	CcSEcCtD
Rivaroxaban—Anaphylactic shock—Prednisone—asthma	6.19e-05	0.000243	CcSEcCtD
Rivaroxaban—Oedema—Prednisone—asthma	6.19e-05	0.000243	CcSEcCtD
Rivaroxaban—CYP3A5—Metapathway biotransformation—GSTM1—asthma	6.19e-05	0.00115	CbGpPWpGaD
Rivaroxaban—Abdominal pain—Methylprednisolone—asthma	6.18e-05	0.000242	CcSEcCtD
Rivaroxaban—Infection—Prednisone—asthma	6.15e-05	0.000241	CcSEcCtD
Rivaroxaban—CYP2J2—Metabolism—ALDH2—asthma	6.15e-05	0.00114	CbGpPWpGaD
Rivaroxaban—Gastrointestinal disorder—Dexamethasone—asthma	6.14e-05	0.00024	CcSEcCtD
Rivaroxaban—Gastrointestinal disorder—Betamethasone—asthma	6.14e-05	0.00024	CcSEcCtD
Rivaroxaban—Hypersensitivity—Hydrocortisone—asthma	6.13e-05	0.00024	CcSEcCtD
Rivaroxaban—Fatigue—Dexamethasone—asthma	6.13e-05	0.00024	CcSEcCtD
Rivaroxaban—Fatigue—Betamethasone—asthma	6.13e-05	0.00024	CcSEcCtD
Rivaroxaban—Shock—Prednisone—asthma	6.09e-05	0.000239	CcSEcCtD
Rivaroxaban—Pain—Dexamethasone—asthma	6.08e-05	0.000238	CcSEcCtD
Rivaroxaban—Pain—Betamethasone—asthma	6.08e-05	0.000238	CcSEcCtD
Rivaroxaban—Nervous system disorder—Prednisone—asthma	6.07e-05	0.000238	CcSEcCtD
Rivaroxaban—Tachycardia—Prednisone—asthma	6.04e-05	0.000237	CcSEcCtD
Rivaroxaban—F10—Metabolism of proteins—LEP—asthma	6.04e-05	0.00112	CbGpPWpGaD
Rivaroxaban—F10—Hemostasis—SERPINE1—asthma	6.02e-05	0.00112	CbGpPWpGaD
Rivaroxaban—Skin disorder—Prednisone—asthma	6.02e-05	0.000236	CcSEcCtD
Rivaroxaban—F10—Hemostasis—ALB—asthma	6.01e-05	0.00112	CbGpPWpGaD
Rivaroxaban—Asthenia—Hydrocortisone—asthma	5.97e-05	0.000234	CcSEcCtD
Rivaroxaban—CYP2J2—Metabolism of lipids and lipoproteins—POMC—asthma	5.91e-05	0.0011	CbGpPWpGaD
Rivaroxaban—Pruritus—Hydrocortisone—asthma	5.89e-05	0.000231	CcSEcCtD
Rivaroxaban—Feeling abnormal—Betamethasone—asthma	5.86e-05	0.000229	CcSEcCtD
Rivaroxaban—Feeling abnormal—Dexamethasone—asthma	5.86e-05	0.000229	CcSEcCtD
Rivaroxaban—CYP2J2—Metabolism—GSTT1—asthma	5.85e-05	0.00109	CbGpPWpGaD
Rivaroxaban—Gastrointestinal pain—Dexamethasone—asthma	5.82e-05	0.000228	CcSEcCtD
Rivaroxaban—Gastrointestinal pain—Betamethasone—asthma	5.82e-05	0.000228	CcSEcCtD
Rivaroxaban—F10—Hemostasis—RHOA—asthma	5.81e-05	0.00108	CbGpPWpGaD
Rivaroxaban—Hypersensitivity—Triamcinolone—asthma	5.77e-05	0.000226	CcSEcCtD
Rivaroxaban—Hypersensitivity—Methylprednisolone—asthma	5.76e-05	0.000226	CcSEcCtD
Rivaroxaban—F10—Hemostasis—NOS3—asthma	5.75e-05	0.00107	CbGpPWpGaD
Rivaroxaban—Diarrhoea—Hydrocortisone—asthma	5.69e-05	0.000223	CcSEcCtD
Rivaroxaban—Urticaria—Dexamethasone—asthma	5.65e-05	0.000221	CcSEcCtD
Rivaroxaban—Urticaria—Betamethasone—asthma	5.65e-05	0.000221	CcSEcCtD
Rivaroxaban—ABCB1—Integrated Pancreatic Cancer Pathway—ESR2—asthma	5.64e-05	0.00105	CbGpPWpGaD
Rivaroxaban—Dizziness—Prednisolone—asthma	5.64e-05	0.000221	CcSEcCtD
Rivaroxaban—Asthenia—Triamcinolone—asthma	5.62e-05	0.00022	CcSEcCtD
Rivaroxaban—Abdominal pain—Dexamethasone—asthma	5.62e-05	0.00022	CcSEcCtD
Rivaroxaban—Abdominal pain—Betamethasone—asthma	5.62e-05	0.00022	CcSEcCtD
Rivaroxaban—Asthenia—Methylprednisolone—asthma	5.61e-05	0.00022	CcSEcCtD
Rivaroxaban—Pruritus—Triamcinolone—asthma	5.54e-05	0.000217	CcSEcCtD
Rivaroxaban—ABCB1—Integrated Pancreatic Cancer Pathway—IL3—asthma	5.54e-05	0.00103	CbGpPWpGaD
Rivaroxaban—Pruritus—Methylprednisolone—asthma	5.53e-05	0.000217	CcSEcCtD
Rivaroxaban—Dizziness—Hydrocortisone—asthma	5.5e-05	0.000216	CcSEcCtD
Rivaroxaban—Dyspepsia—Prednisone—asthma	5.45e-05	0.000213	CcSEcCtD
Rivaroxaban—CYP2J2—Metabolism of lipids and lipoproteins—ALB—asthma	5.39e-05	0.001	CbGpPWpGaD
Rivaroxaban—Rash—Prednisolone—asthma	5.37e-05	0.00021	CcSEcCtD
Rivaroxaban—Dermatitis—Prednisolone—asthma	5.37e-05	0.00021	CcSEcCtD
Rivaroxaban—Diarrhoea—Methylprednisolone—asthma	5.35e-05	0.00021	CcSEcCtD
Rivaroxaban—Fatigue—Prednisone—asthma	5.34e-05	0.000209	CcSEcCtD
Rivaroxaban—Headache—Prednisolone—asthma	5.34e-05	0.000209	CcSEcCtD
Rivaroxaban—Constipation—Prednisone—asthma	5.3e-05	0.000207	CcSEcCtD
Rivaroxaban—Vomiting—Hydrocortisone—asthma	5.29e-05	0.000207	CcSEcCtD
Rivaroxaban—Rash—Hydrocortisone—asthma	5.25e-05	0.000206	CcSEcCtD
Rivaroxaban—Dermatitis—Hydrocortisone—asthma	5.24e-05	0.000205	CcSEcCtD
Rivaroxaban—Headache—Hydrocortisone—asthma	5.21e-05	0.000204	CcSEcCtD
Rivaroxaban—ABCB1—Allograft Rejection—IFNG—asthma	5.19e-05	0.000966	CbGpPWpGaD
Rivaroxaban—F10—Metabolism of proteins—POMC—asthma	5.19e-05	0.000966	CbGpPWpGaD
Rivaroxaban—Dizziness—Triamcinolone—asthma	5.18e-05	0.000203	CcSEcCtD
Rivaroxaban—Dizziness—Methylprednisolone—asthma	5.17e-05	0.000202	CcSEcCtD
Rivaroxaban—Feeling abnormal—Prednisone—asthma	5.1e-05	0.0002	CcSEcCtD
Rivaroxaban—Asthenia—Betamethasone—asthma	5.1e-05	0.0002	CcSEcCtD
Rivaroxaban—Asthenia—Dexamethasone—asthma	5.1e-05	0.0002	CcSEcCtD
Rivaroxaban—F10—Metabolism of proteins—CCL2—asthma	5.08e-05	0.000945	CbGpPWpGaD
Rivaroxaban—Gastrointestinal pain—Prednisone—asthma	5.06e-05	0.000198	CcSEcCtD
Rivaroxaban—Nausea—Prednisolone—asthma	5.06e-05	0.000198	CcSEcCtD
Rivaroxaban—Pruritus—Dexamethasone—asthma	5.03e-05	0.000197	CcSEcCtD
Rivaroxaban—Pruritus—Betamethasone—asthma	5.03e-05	0.000197	CcSEcCtD
Rivaroxaban—Vomiting—Triamcinolone—asthma	4.98e-05	0.000195	CcSEcCtD
Rivaroxaban—ABCB1—Integrated Pancreatic Cancer Pathway—NTRK1—asthma	4.98e-05	0.000928	CbGpPWpGaD
Rivaroxaban—Vomiting—Methylprednisolone—asthma	4.97e-05	0.000195	CcSEcCtD
Rivaroxaban—Nausea—Hydrocortisone—asthma	4.94e-05	0.000194	CcSEcCtD
Rivaroxaban—Rash—Triamcinolone—asthma	4.94e-05	0.000194	CcSEcCtD
Rivaroxaban—Dermatitis—Triamcinolone—asthma	4.94e-05	0.000193	CcSEcCtD
Rivaroxaban—Rash—Methylprednisolone—asthma	4.93e-05	0.000193	CcSEcCtD
Rivaroxaban—Dermatitis—Methylprednisolone—asthma	4.93e-05	0.000193	CcSEcCtD
Rivaroxaban—Urticaria—Prednisone—asthma	4.92e-05	0.000193	CcSEcCtD
Rivaroxaban—Headache—Triamcinolone—asthma	4.91e-05	0.000192	CcSEcCtD
Rivaroxaban—Headache—Methylprednisolone—asthma	4.9e-05	0.000192	CcSEcCtD
Rivaroxaban—Abdominal pain—Prednisone—asthma	4.9e-05	0.000192	CcSEcCtD
Rivaroxaban—F10—Hemostasis—IL2—asthma	4.88e-05	0.000908	CbGpPWpGaD
Rivaroxaban—Diarrhoea—Betamethasone—asthma	4.87e-05	0.000191	CcSEcCtD
Rivaroxaban—Diarrhoea—Dexamethasone—asthma	4.87e-05	0.000191	CcSEcCtD
Rivaroxaban—CYP2J2—Metabolism—NQO1—asthma	4.86e-05	0.000905	CbGpPWpGaD
Rivaroxaban—ABCB1—Transmembrane transport of small molecules—SLC26A4—asthma	4.84e-05	0.000902	CbGpPWpGaD
Rivaroxaban—ABCB1—Allograft Rejection—CXCL8—asthma	4.83e-05	0.000898	CbGpPWpGaD
Rivaroxaban—CYP3A4—Biological oxidations—ALDH2—asthma	4.82e-05	0.000897	CbGpPWpGaD
Rivaroxaban—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—asthma	4.79e-05	0.000892	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism—ADCY2—asthma	4.75e-05	0.000885	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism of lipids and lipoproteins—PTGS2—asthma	4.71e-05	0.000878	CbGpPWpGaD
Rivaroxaban—Dizziness—Dexamethasone—asthma	4.7e-05	0.000184	CcSEcCtD
Rivaroxaban—Dizziness—Betamethasone—asthma	4.7e-05	0.000184	CcSEcCtD
Rivaroxaban—Nausea—Triamcinolone—asthma	4.66e-05	0.000182	CcSEcCtD
Rivaroxaban—Nausea—Methylprednisolone—asthma	4.64e-05	0.000182	CcSEcCtD
Rivaroxaban—ABCB1—Allograft Rejection—IL1B—asthma	4.63e-05	0.000862	CbGpPWpGaD
Rivaroxaban—ABCB1—Allograft Rejection—IL2—asthma	4.61e-05	0.000859	CbGpPWpGaD
Rivaroxaban—CYP3A4—Biological oxidations—GSTT1—asthma	4.58e-05	0.000853	CbGpPWpGaD
Rivaroxaban—Hypersensitivity—Prednisone—asthma	4.56e-05	0.000179	CcSEcCtD
Rivaroxaban—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—asthma	4.56e-05	0.000849	CbGpPWpGaD
Rivaroxaban—ABCB1—HIF-1-alpha transcription factor network—VEGFA—asthma	4.53e-05	0.000842	CbGpPWpGaD
Rivaroxaban—Vomiting—Betamethasone—asthma	4.52e-05	0.000177	CcSEcCtD
Rivaroxaban—Vomiting—Dexamethasone—asthma	4.52e-05	0.000177	CcSEcCtD
Rivaroxaban—Rash—Betamethasone—asthma	4.48e-05	0.000176	CcSEcCtD
Rivaroxaban—Rash—Dexamethasone—asthma	4.48e-05	0.000176	CcSEcCtD
Rivaroxaban—Dermatitis—Betamethasone—asthma	4.48e-05	0.000175	CcSEcCtD
Rivaroxaban—Dermatitis—Dexamethasone—asthma	4.48e-05	0.000175	CcSEcCtD
Rivaroxaban—Headache—Betamethasone—asthma	4.45e-05	0.000174	CcSEcCtD
Rivaroxaban—Headache—Dexamethasone—asthma	4.45e-05	0.000174	CcSEcCtD
Rivaroxaban—Asthenia—Prednisone—asthma	4.44e-05	0.000174	CcSEcCtD
Rivaroxaban—CYP3A5—Biological oxidations—POMC—asthma	4.44e-05	0.000826	CbGpPWpGaD
Rivaroxaban—ABCB1—Transmembrane transport of small molecules—ATP4A—asthma	4.43e-05	0.000825	CbGpPWpGaD
Rivaroxaban—ABCB1—Transmembrane transport of small molecules—SLC30A8—asthma	4.43e-05	0.000825	CbGpPWpGaD
Rivaroxaban—Pruritus—Prednisone—asthma	4.38e-05	0.000172	CcSEcCtD
Rivaroxaban—ABCB1—Integrated Pancreatic Cancer Pathway—PLA2G4A—asthma	4.35e-05	0.000811	CbGpPWpGaD
Rivaroxaban—Diarrhoea—Prednisone—asthma	4.24e-05	0.000166	CcSEcCtD
Rivaroxaban—Nausea—Betamethasone—asthma	4.22e-05	0.000165	CcSEcCtD
Rivaroxaban—Nausea—Dexamethasone—asthma	4.22e-05	0.000165	CcSEcCtD
Rivaroxaban—CYP3A5—Metabolism—LTC4S—asthma	4.18e-05	0.000779	CbGpPWpGaD
Rivaroxaban—F10—Hemostasis—VEGFA—asthma	4.14e-05	0.000771	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism of lipids and lipoproteins—PTEN—asthma	4.11e-05	0.000765	CbGpPWpGaD
Rivaroxaban—Dizziness—Prednisone—asthma	4.1e-05	0.00016	CcSEcCtD
Rivaroxaban—CYP2J2—Metabolism—GSTP1—asthma	4.05e-05	0.000754	CbGpPWpGaD
Rivaroxaban—F10—Metabolism of proteins—CXCL8—asthma	4.01e-05	0.000747	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism—HMOX1—asthma	4e-05	0.000744	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism—ITPR1—asthma	3.99e-05	0.000742	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism—CAT—asthma	3.94e-05	0.000734	CbGpPWpGaD
Rivaroxaban—Vomiting—Prednisone—asthma	3.94e-05	0.000154	CcSEcCtD
Rivaroxaban—ABCB1—Allograft Rejection—VEGFA—asthma	3.92e-05	0.00073	CbGpPWpGaD
Rivaroxaban—Rash—Prednisone—asthma	3.9e-05	0.000153	CcSEcCtD
Rivaroxaban—Dermatitis—Prednisone—asthma	3.9e-05	0.000153	CcSEcCtD
Rivaroxaban—CYP3A4—Phase 1 - Functionalization of compounds—POMC—asthma	3.88e-05	0.000723	CbGpPWpGaD
Rivaroxaban—Headache—Prednisone—asthma	3.88e-05	0.000152	CcSEcCtD
Rivaroxaban—F10—Hemostasis—TGFB1—asthma	3.8e-05	0.000708	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism—PLA2G4A—asthma	3.72e-05	0.000693	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism—GSTM1—asthma	3.72e-05	0.000693	CbGpPWpGaD
Rivaroxaban—Nausea—Prednisone—asthma	3.68e-05	0.000144	CcSEcCtD
Rivaroxaban—ABCB1—Integrated Pancreatic Cancer Pathway—CDK2—asthma	3.63e-05	0.000677	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—LTA4H—asthma	3.63e-05	0.000675	CbGpPWpGaD
Rivaroxaban—ABCB1—Allograft Rejection—TGFB1—asthma	3.6e-05	0.00067	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism—PPP2CA—asthma	3.43e-05	0.000638	CbGpPWpGaD
Rivaroxaban—ABCB1—Allograft Rejection—TNF—asthma	3.36e-05	0.000625	CbGpPWpGaD
Rivaroxaban—CYP3A4—Biological oxidations—GSTP1—asthma	3.18e-05	0.000591	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—ARG1—asthma	3.17e-05	0.00059	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—LTC4S—asthma	3.16e-05	0.000588	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metapathway biotransformation—GSTP1—asthma	3.13e-05	0.000583	CbGpPWpGaD
Rivaroxaban—ABCB1—Transmembrane transport of small molecules—CARM1—asthma	2.98e-05	0.000554	CbGpPWpGaD
Rivaroxaban—CYP3A4—Biological oxidations—GSTM1—asthma	2.92e-05	0.000543	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metapathway biotransformation—GSTM1—asthma	2.88e-05	0.000536	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—ALDH7A1—asthma	2.87e-05	0.000534	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—ARG2—asthma	2.75e-05	0.000512	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—LTA4H—asthma	2.74e-05	0.00051	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism—POMC—asthma	2.63e-05	0.00049	CbGpPWpGaD
Rivaroxaban—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—asthma	2.58e-05	0.000481	CbGpPWpGaD
Rivaroxaban—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—asthma	2.46e-05	0.000457	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism—ALB—asthma	2.4e-05	0.000447	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—ARG1—asthma	2.39e-05	0.000445	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism—NOS3—asthma	2.3e-05	0.000427	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—ALOX5AP—asthma	2.28e-05	0.000424	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—ALOX15—asthma	2.28e-05	0.000424	CbGpPWpGaD
Rivaroxaban—ABCB1—Transmembrane transport of small molecules—ADCY2—asthma	2.21e-05	0.000411	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—CHAT—asthma	2.17e-05	0.000405	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—ALDH7A1—asthma	2.16e-05	0.000403	CbGpPWpGaD
Rivaroxaban—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—asthma	2.14e-05	0.000399	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism—PTGS2—asthma	2.1e-05	0.000391	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—ARG2—asthma	2.07e-05	0.000386	CbGpPWpGaD
Rivaroxaban—CYP3A4—Biological oxidations—POMC—asthma	2.06e-05	0.000384	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—LTC4S—asthma	1.94e-05	0.000362	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—ALOX5—asthma	1.94e-05	0.000361	CbGpPWpGaD
Rivaroxaban—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—asthma	1.93e-05	0.00036	CbGpPWpGaD
Rivaroxaban—ABCB1—Transmembrane transport of small molecules—HMOX1—asthma	1.86e-05	0.000345	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—CARM1—asthma	1.85e-05	0.000344	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism—PTEN—asthma	1.83e-05	0.000341	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—DCN—asthma	1.82e-05	0.000339	CbGpPWpGaD
Rivaroxaban—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—asthma	1.78e-05	0.00033	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—ALDH2—asthma	1.77e-05	0.00033	CbGpPWpGaD
Rivaroxaban—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—asthma	1.74e-05	0.000324	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—ALOX5AP—asthma	1.72e-05	0.00032	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—ALOX15—asthma	1.72e-05	0.00032	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—LTA4H—asthma	1.69e-05	0.000314	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—GSTT1—asthma	1.68e-05	0.000314	CbGpPWpGaD
Rivaroxaban—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—asthma	1.66e-05	0.000309	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—CHAT—asthma	1.64e-05	0.000305	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—ARG1—asthma	1.47e-05	0.000274	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—ALOX5—asthma	1.46e-05	0.000272	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—NQO1—asthma	1.4e-05	0.000261	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—CARM1—asthma	1.39e-05	0.00026	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—DCN—asthma	1.37e-05	0.000256	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—ADCY2—asthma	1.37e-05	0.000255	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—ALDH2—asthma	1.34e-05	0.000249	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—ALDH7A1—asthma	1.33e-05	0.000248	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—ARG2—asthma	1.28e-05	0.000238	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—GSTT1—asthma	1.27e-05	0.000237	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—GSTP1—asthma	1.17e-05	0.000217	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—HMOX1—asthma	1.15e-05	0.000214	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—ITPR1—asthma	1.15e-05	0.000214	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—CAT—asthma	1.14e-05	0.000212	CbGpPWpGaD
Rivaroxaban—ABCB1—Transmembrane transport of small molecules—ALB—asthma	1.11e-05	0.000207	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—PLA2G4A—asthma	1.07e-05	0.0002	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—GSTM1—asthma	1.07e-05	0.0002	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—ALOX5AP—asthma	1.06e-05	0.000197	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—ALOX15—asthma	1.06e-05	0.000197	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—NQO1—asthma	1.06e-05	0.000197	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—ADCY2—asthma	1.03e-05	0.000193	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—CHAT—asthma	1.01e-05	0.000188	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—PPP2CA—asthma	9.88e-06	0.000184	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—ALOX5—asthma	9e-06	0.000168	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—GSTP1—asthma	8.81e-06	0.000164	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—HMOX1—asthma	8.69e-06	0.000162	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—ITPR1—asthma	8.67e-06	0.000161	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—CARM1—asthma	8.59e-06	0.00016	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—CAT—asthma	8.58e-06	0.00016	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—DCN—asthma	8.47e-06	0.000158	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—ALDH2—asthma	8.24e-06	0.000153	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—GSTM1—asthma	8.1e-06	0.000151	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—PLA2G4A—asthma	8.1e-06	0.000151	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—GSTT1—asthma	7.83e-06	0.000146	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—POMC—asthma	7.59e-06	0.000141	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—PPP2CA—asthma	7.46e-06	0.000139	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—ALB—asthma	6.92e-06	0.000129	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—NOS3—asthma	6.62e-06	0.000123	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—NQO1—asthma	6.51e-06	0.000121	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—ADCY2—asthma	6.37e-06	0.000119	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—PTGS2—asthma	6.05e-06	0.000113	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—POMC—asthma	5.72e-06	0.000107	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—GSTP1—asthma	5.43e-06	0.000101	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—HMOX1—asthma	5.35e-06	9.97e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—ITPR1—asthma	5.34e-06	9.95e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—CAT—asthma	5.28e-06	9.84e-05	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—PTEN—asthma	5.28e-06	9.82e-05	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—ALB—asthma	5.22e-06	9.72e-05	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—NOS3—asthma	4.99e-06	9.29e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—GSTM1—asthma	4.99e-06	9.29e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—PLA2G4A—asthma	4.99e-06	9.29e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—PPP2CA—asthma	4.6e-06	8.56e-05	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—PTGS2—asthma	4.57e-06	8.5e-05	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—PTEN—asthma	3.98e-06	7.41e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—POMC—asthma	3.53e-06	6.57e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—ALB—asthma	3.22e-06	5.99e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—NOS3—asthma	3.08e-06	5.73e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—PTGS2—asthma	2.81e-06	5.24e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—PTEN—asthma	2.45e-06	4.57e-05	CbGpPWpGaD
